000			02099 a2200565 4500
005			20250515180933.0
264		0	_c20091208
008			200912s 0 0 eng d
022			_a1592-8721
024	7		_a10.3324/haematol.2009.006981 _2doi
040			_aNLM _beng _cNLM
100	1		_aErnst, Thomas
245	0	0	_aA co-operative evaluation of different methods of detecting BCR-ABL kinase domain mutations in patients with chronic myeloid leukemia on second-line dasatinib or nilotinib therapy after failure of imatinib. _h[electronic resource]
260			_bHaematologica _cSep 2009
300			_a1227-35 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aBenzamides
650	0	4	_aDNA Mutational Analysis
650	0	4	_aDasatinib
650	0	4	_aDrug Resistance, Neoplasm _xdrug effects
650	0	4	_aFemale
650	0	4	_aFusion Proteins, bcr-abl _xantagonists & inhibitors
650	0	4	_aHumans
650	0	4	_aImatinib Mesylate
650	0	4	_aLeukemia, Myelogenous, Chronic, BCR-ABL Positive _xdrug therapy
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMutation
650	0	4	_aPiperazines _xadministration & dosage
650	0	4	_aPolymerase Chain Reaction
650	0	4	_aProtein Kinase Inhibitors _xadministration & dosage
650	0	4	_aProtein Structure, Tertiary _xgenetics
650	0	4	_aProtein-Tyrosine Kinases _xantagonists & inhibitors
650	0	4	_aPyrimidines _xadministration & dosage
650	0	4	_aThiazoles _xadministration & dosage
700	1		_aGruber, Franz X
700	1		_aPelz-Ackermann, Oliver
700	1		_aMaier, Jacqueline
700	1		_aPfirrmann, Markus
700	1		_aMüller, Martin C
700	1		_aMikkola, Ingvild
700	1		_aPorkka, Kimmo
700	1		_aNiederwieser, Dietger
700	1		_aHochhaus, Andreas
700	1		_aLange, Thoralf
773	0		_tHaematologica _gvol. 94 _gno. 9 _gp. 1227-35
856	4	0	_uhttps://doi.org/10.3324/haematol.2009.006981 _zAvailable from publisher's website
999			_c19021875 _d19021875